Get the Stockscreener App
2.435
0.83%
0.02
Minerva Neurosciences Inc Stock (NERV) Forecast
The Minerva Neurosciences Inc (NERV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $11.88, representing a +388.09% increase from the current price of $2.435. The highest analyst price target is $11.48, and the lowest is $12.29.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month NERV Price Target
Average 11.21
(+360.26% Upside)
Is Minerva Neurosciences Inc (NERV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 65.30 | Neutral |
| STOCH(9,6) | 54.64 | Neutral |
| STOCHRSI(14) | 70.43 | Neutral |
| MACD(12,26) | 0.0959 | Buy |
| ADX(14) | 33.45 | Buy |
| William %R | -37.56 | Neutral |
| CCI(14) | 110.87 | Buy |
Buy: 3
Sell: 0
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.9946
Buy
|
2.0922
Buy
|
| MA20 |
1.9763
Buy
|
2.0002
Buy
|
| MA50 |
1.8697
Buy
|
1.8905
Buy
|
| MA100 |
1.734
Buy
|
1.8549
Buy
|
| MA200 |
1.9167
Buy
|
1.9947
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, NERV could be considered a Strong Buy, with 17 technical analysis indicators signaling 13 Buy signals, 0 signaling Sell signals and 4 Neutral signals. This might be a good time to open fresh positions on NERV, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 65.3 indicates that NERV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 54.64 indicates that NERV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 70.43 indicates that NERV is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.45 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 110.87 indicates that NERV is overbought. This means that the price has moved significantly higher than its average, indicating a potential selling opportunity.
Long-term NERV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Minerva Neurosciences Inc financial reports and earnings history, Minerva Neurosciences Inc (NERV) stock could reach $61.50 by 2030, $38.43 by 2040 and $117.16 by 2050. See the projected annual prices until 2050 of the Minerva Neurosciences Inc stock below:
- Minerva Neurosciences Inc (NERV) is expected to reach an average price of $9.0436 in 2035, with a high prediction of $10.55 and a low estimate of $9.3536. This indicates an $271.40% rise from the last recorded price of $2.435.
- Minerva Neurosciences Inc (NERV) stock is projected to chart a bullish course in 2040, with an average price target of $35.78, representing an $1,370% surge from its current level. The forecast ranges from a conservative $36.32 to a sky-high $38.43.
- Our analysts predict Minerva Neurosciences Inc (NERV) to jump 2,537% by 2045, soaring from $64.83 to an average price of $64.20, potentially reaching $65.51. While $64.83 is the low estimate, the potential upside is significant.
- Minerva Neurosciences Inc (NERV) stock is expected to climb by 2050, reaching an average of $114.23, a $4,591% jump from its current level. However, a wide range of estimates exists, with high and low targets of $117.16 and $115.33, respectively, highlighting the market's uncertainty.
Minerva Neurosciences Inc Stock (NERV) Year by Year Forecast
Minerva Neurosciences Inc Stock (NERV) Price Forecast for 2025
Minerva Neurosciences Inc Stock (NERV) is expected to reach an average price of $39.91 in 2025, with a high prediction of $79.72 and a low estimate of $0.1126. This indicates an +1,539% rise from the last recorded price of $2.435.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2025 | $11.41 | $12.29 | $11.48 | +368.56% |
| October, 2025 | $15.92 | $13.08 | $13.69 | +553.69% |
| November, 2025 | $13.16 | $13.76 | $14.55 | +440.27% |
| December, 2025 | $12.06 | $12.48 | $12.35 | +395.42% |
Minerva Neurosciences Inc Stock (NERV) Price Forecast for 2026
The predicted value for Minerva Neurosciences Inc (NERV) in 2026 is set at an average of $11.21. Estimates vary from a peak of $16.24 to a trough of $6.1713, indicating an +360.26% surge from the present price of $2.435.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $4.9817 | $8.0217 | $9.573 | +104.59% |
| February, 2026 | $15.70 | $6.1713 | $14.66 | +544.76% |
| March, 2026 | $14.02 | $15.50 | $16.24 | +475.70% |
| April, 2026 | $6.1262 | $8.2102 | $7.4374 | +151.59% |
| May, 2026 | $9.7645 | $9.9245 | $8.7613 | +301.00% |
| June, 2026 | $12.12 | $10.36 | $9.8236 | +397.85% |
| July, 2026 | $9.1906 | $14.26 | $12.80 | +277.44% |
| August, 2026 | $8.7489 | $9.0657 | $8.1194 | +259.30% |
| September, 2026 | $13.10 | $11.18 | $12.30 | +437.86% |
| October, 2026 | $15.78 | $15.48 | $15.62 | +547.85% |
| November, 2026 | $15.01 | $15.26 | $15.44 | +516.57% |
| December, 2026 | $14.96 | $15.48 | $14.90 | +514.43% |
Minerva Neurosciences Inc Stock (NERV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Minerva Neurosciences Inc (NERV) is $17.75, with a high forecast of $19.03 and a low forecast of $16.47. This indicates an +628.88% increase from the last price of $2.435.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $18.04 | $16.47 | $17.26 | +640.84% |
| February, 2027 | $18.56 | $17.37 | $16.75 | +662.13% |
| March, 2027 | $19.24 | $19.11 | $19.03 | +690.22% |
| April, 2027 | $19.30 | $19.58 | $18.79 | +692.81% |
| May, 2027 | $19.30 | $19.30 | $19.00 | +692.70% |
| June, 2027 | $19.09 | $19.09 | $18.79 | +683.99% |
| July, 2027 | $17.13 | $17.57 | $18.52 | +603.36% |
| August, 2027 | $17.80 | $16.96 | $16.94 | +630.92% |
| September, 2027 | $18.79 | $18.99 | $18.79 | +671.86% |
| October, 2027 | $18.39 | $18.75 | $18.50 | +655.33% |
| November, 2027 | $17.48 | $17.69 | $17.97 | +617.92% |
| December, 2027 | $16.73 | $16.91 | $17.49 | +587.03% |
Minerva Neurosciences Inc Stock (NERV) Price Forecast for 2028
In 2028, Minerva Neurosciences Inc (NERV) is projected to reach an average price of $10.66, with a high projection of $16.18 and a low estimate of $5.1379. This indicates an +337.71% rise from the last price of $2.435.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $10.12 | $10.15 | $16.18 | +315.50% |
| February, 2028 | $9.4257 | $9.9457 | $9.0362 | +287.09% |
| March, 2028 | $15.15 | $8.7649 | $14.94 | +522.33% |
| April, 2028 | $13.70 | $13.72 | $14.64 | +462.71% |
| May, 2028 | $13.79 | $13.45 | $13.37 | +466.32% |
| June, 2028 | $13.64 | $13.73 | $14.21 | +460.09% |
| July, 2028 | $12.48 | $12.54 | $12.98 | +412.38% |
| August, 2028 | $12.39 | $12.22 | $12.19 | +408.80% |
| September, 2028 | $11.74 | $11.79 | $12.00 | +382.24% |
| October, 2028 | $6.6908 | $9.5808 | $10.69 | +174.78% |
| November, 2028 | $5.2087 | $5.8787 | $5.7891 | +113.91% |
| December, 2028 | $2.017 | $5.1379 | $4.6674 | -17.17% |
Minerva Neurosciences Inc Stock (NERV) Price Forecast for 2029
The 2029 price forecast for Minerva Neurosciences Inc Stock (NERV) is $22.08 on average, with a high prediction of $44.16 and a low estimate of $0.00617. This represents an +806.90% increase from the previous price of $2.435.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.7949 | $0.2762 | $2.4037 | -67.36% |
| February, 2029 | $0.5532 | $1.2235 | $0.5655 | -77.28% |
| March, 2029 | $1.1615 | $1.1423 | $0.6123 | -52.30% |
| April, 2029 | $2.5498 | $1.2611 | $1.5198 | +4.71% |
| May, 2029 | $3.3076 | $2.7994 | $2.7985 | +35.83% |
| June, 2029 | $0.524 | $0.073 | $1.9568 | -78.48% |
| July, 2029 | $0.1057 | $0.0343 | $0.8607 | -95.66% |
| August, 2029 | $3.2579 | $0.00617 | $3.7079 | +33.79% |
| September, 2029 | $2.3596 | $1.2896 | $8.6387 | -3.10% |
| October, 2029 | $0.9883 | $1.0983 | $3.19 | -59.41% |
| November, 2029 | $0.4966 | $0.6902 | $0.7379 | -79.61% |
| December, 2029 | $50.00 | $0.1533 | $44.16 | +1,953% |
Minerva Neurosciences Inc Stock (NERV) Price Forecast for 2030
Minerva Neurosciences Inc Stock (NERV) is expected to reach an average price of $45.07 in 2030, with a high forecast of $65.95 and a low forecast of $24.18. This signifies an +1,751% surge from the last price of $2.435.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $67.66 | $58.38 | $61.50 | +2,678% |
| February, 2030 | $49.65 | $50.21 | $65.95 | +1,939% |
| March, 2030 | $49.01 | $49.17 | $48.48 | +1,913% |
| April, 2030 | $42.29 | $46.15 | $43.05 | +1,637% |
| May, 2030 | $35.62 | $34.28 | $38.82 | +1,363% |
| June, 2030 | $63.42 | $60.16 | $61.70 | +2,504% |
| July, 2030 | $46.35 | $54.81 | $56.54 | +1,804% |
| August, 2030 | $44.99 | $43.29 | $42.85 | +1,748% |
| September, 2030 | $29.03 | $35.27 | $34.59 | +1,092% |
| October, 2030 | $19.98 | $24.84 | $22.00 | +720.64% |
| November, 2030 | $39.96 | $24.18 | $24.84 | +1,541% |
| December, 2030 | $45.24 | $40.70 | $40.28 | +1,758% |
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):